Home > News > Nucryst Pharmaceuticals granted new acne patent
March 9th, 2006
Nucryst Pharmaceuticals granted new acne patent
Abstract:
Nucryst Pharmaceuticals has been granted a new patent that covers the company’s proprietary nanocrystalline silver for use in the treatment of acne. This latest addition strengthens the company’s patent portfolio, which now covers the top three dermatology diseases.
Source:
drugresearcher.com
Related News Press |
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Personal Care/Cosmetics
DGIST and New Life Group launched a research project on "Functional beauty and health products using the latest nanotechnology" May 12th, 2023
A Comprehensive Guide: The Future of Nanotechnology September 13th, 2018
Graphene finds new application as anti-static hair dye: New formula works as well as commercial permanent dyes without chemically altering hairs March 22nd, 2018
Programmable materials find strength in molecular repetition May 23rd, 2016
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||